4/A: Joshua Horowitz Reports Correction and Acquisition of NeuroMetrix Stock

Director Joshua Horowitz files amended Form 4 to correct a previous error and reports acquisition of NeuroMetrix, Inc. stock.

Summary

• Joshua Horowitz, a director of NeuroMetrix, Inc., filed an amended Form 4 with the SEC.
• The amendment corrects an error in the total number of restricted stock units (RSUs) issued, as reported on a previous filing on April 30, 2024.
• Horowitz acquired 369 shares of common stock at $0 and 6,000 RSUs at $4.32 on February 3, 2025.
• Each RSU represents the right to receive one share of common stock and vests 100% upon issuance.
• Following these transactions, Horowitz directly owns 29,807 shares of common stock and indirectly owns 60,500 shares through Palm Management (US) LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions. The acquisition of shares and RSUs could be interpreted slightly positively, but it's not a major event.

Positives

• The acquisition of additional shares and RSUs by a director could be seen as a positive signal regarding their confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The correction of a previous filing indicates attention to detail and compliance with SEC regulations.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The acquisition of shares and RSUs by a director could potentially increase investor confidence.

Key Dates

Keywords

Form 4, NeuroMetrix, Director, Joshua Horowitz, Stock Acquisition, RSUs, Beneficial Ownership